Lily Vakili Photo

Industry Experience

Director and Counsel

UBS, New York Branch

Lily represents public and private companies in strategic collaborations, complex product licensing, research and development, and distribution and co-promotion agreements. She advises early stage start-ups, generics manufacturers, and international pharmaceutical corporations, and assists clients in the negotiation of clinical and commercial manufacturing and supply chain agreements for both small molecules and biologics.

experience +

experience –

New York Branch of UBS

Director and Counsel

  • Represented the bank in connection with domestic and international syndicated loan and complex financings.

Simpson Thacher & Bartlett

Corporate Department Associate

  • Focused on international banking and finance transactions

Sidley Austin

Member of business transactions group

Recent Client Work +

Recent Client WOrk –

  • Representation of ImmunoGen Inc., a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer, in the drafting and negotiation of multiple development, clinical manufacturing, and commercial manufacturing agreements
  • Establishing customized CMC supply chain documentation, including the negotiation of clinical and commercial manufacturing agreements, on behalf of Sage Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system disorders, including a proprietary IV formulation of brexanolone for the treatment of postpartum depression
  • Manufacturing and supply documentation for Atara Biotherapeutics’ exclusive license of clinical-stage T-cell therapy technology from Memorial Sloan Kettering Cancer Center
  • Exclusive worldwide license and collaboration agreement between Gilead Sciences, Inc. and GlobeImmune, Inc. for the development and commercialization of therapeutic vaccine products for use in conjunction with oral therapies for the treatment of chronic hepatitis B virus (HBV) infection
  • Exclusive in-license of QRxPharma’s dual-opioid pain product, MoxDuo IR, by international generic pharmaceuticals company, Actavis Group’s, U.S. subsidiary, Actavis, Inc.
  • Representation of a privately held pharmaceutical company in a development and manufacturing transaction with a U.S. manufacturing company for the clinical development and manufacture of drugs for the U.S. market designed to treat several serious infections affecting women’s health
  • Commercial supply chain documentation for an early stage, public biopharmaceutical company involved in the development of molecularly targeted product candidates and T-cell product candidates
  • Commercial supply chain documentation for a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women’s health infections

Community +

Community –

Lily is involved with the Harvard Law School Womens Association of New York. She also volunteers with the Montclair, New Jersey Townships Advisory Committee for People with Disabilities. The organization’s mission includes recommending programs, policies and legislation that benefit individuals with disabilities to the Township Council of Montclair.

Bar Admissions
  • New York
Education 
  • ‍Harvard Law School, J.D.
  • University of Minnesota, B.A., summa cum laude, Phi Beta Kappa
Language
  • Spanish